Latest Breaking News On - Globaldata pharma intelligence center - Page 5 : comparemela.com

Indian home-grown Covid-19 shot wins WHO emergency use approval

The World Health Organization (WHO) said on Wednesday that it has granted approval for Indian drugmaker Bharat Biotech's home-grown Covid-19 vaccine for emergency use listing, paving the way for it to be accepted as a valid vaccine in many poor countries.

Saudi arabiaUnited arab emiratesAndhra pradeshPrashant khadayateSinovac biotechStrategic advisory group of experts on immunizationWorld health organizationGlobaldata pharma intelligence centerSerum institute of indiaBharat biotechAdvisory groupPharma intelligence centerSerum institute

Indian home-grown COVID-19 shot wins WHO emergency use approval

The World Health Organization (WHO) said on Wednesday that it has granted approval for Indian drugmaker Bharat Biotech's home-grown COVID-19 vaccine for emergency use listing, paving the way for it to be accepted as a valid vaccine in many poor countries.

Saudi arabiaUnited arab emiratesAndhra pradeshChandini monnappaAnuron kumar mitraJose devasiaShivani singhMark potterPrashant khadayateNick macfieThomson reuters trust principlesSinovac biotechStrategic advisory group of experts on immunizationWorld health organizationGlobaldata pharma intelligence centerSerum institute of india

Indian home-grown COVID-19 shot wins WHO emergency use approval

The World Health Organization (WHO) said on Wednesday that it has granted approval for Indian drugmaker Bharat Biotech's home-grown COVID-19 vaccine for emergency use listing, paving the way for it to be accepted as a valid vaccine in many poor countries.

Saudi arabiaUnited arab emiratesAndhra pradeshPrashant khadayateSinovac biotechStrategic advisory group of experts on immunizationGlobaldata pharma intelligence centerSerum institute of indiaBharat biotechAdvisory groupPharma intelligence centerSerum institute

GlobalData plc (via Public) / Ono Pharma Braftovi approval in South Korea will strengthen oncology portfolio but with limited sales potential, says GlobalData

GlobalData plc (via Public) / Ono Pharma Braftovi approval in South Korea will strengthen oncology portfolio but with limited sales potential, says GlobalData
publicnow.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from publicnow.com Daily Mail and Mail on Sunday newspapers.

South koreaPrashant khadayateMono pharmaceuticalsGlobaldata pharma intelligence centerOno pharmaceuticalArray biopharmaPharma intelligence centerPharma analyst

Chinese patent reforms to bolster pharma innovation

Chinese patent reforms to bolster pharma innovation
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

Asia pacificSasmitha sahuGlobaldata pharma intelligence centerMarketing authorization holderDrug regulation registrationPharma analystPharma intelligence centerஆசியா பெஸிஃபிக்சந்தைப்படுத்தல் அங்கீகாரம் வைத்திருப்பவர்பார்மா ஆய்வாளர்பார்மா உளவுத்துறை மையம்